Under the FTC’s final order, approved by a 5-0 vote, Stryker must sell all assets associated with total ankle replacements and finger joint implants to DJO Global.
The order settles charges brought by the FTC in November alleging the acquisition would violate antitrust law and result in harm to consumers in the U.S. markets for total ankle replacement and finger joint implants.
The FTC approved the final order after a 30-day public comment period.
More articles on supply chain:
Rural California hospitals struggle with state’s new PPE stockpile mandate
Rare disease patients struggle to find PPE
FDA authorizes first fully at-home COVID-19 test
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
